Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer

Based on single agent activities and the additive or synergistic effects of three individual drugs in gastric cancer, we performed a phase II study of a new regimen combining epirubicin, docetaxel and cisplatin (EDP) for unresectable gastric cancer. The patients with histologically confirmed metasta...

Full description

Saved in:
Bibliographic Details
Main Authors: Lee, S-H, Kang, W K, Park, J, Kim, H Y, Kim, J H, Lee, S I, Park, J O, Kim, K, Jung, C W, Park, Y S, Im, Y-H, Lee, M H, Park, K
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2004
Subjects:
Clinical
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2364756/
https://ncbi.nlm.nih.gov/pubmed/15188010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601891
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items